ChrysCapital Management
LPACs: Conflicts and complexity
The combination of a maturing Asian private equity landscape and a fast-emerging continuation fund opportunity is placing greater emphasis on the role of the LP advisory committee
BPEA EQT, ChrysCapital buy HDFC's India education finance unit
BPEA EQT and ChrysCapital have agreed to acquire a 90% stake in India-based HDFC’s education finance business at a valuation of INR 103.5bn (USD 1.26bn). It has been described as the largest-ever private equity buyout in the country’s financial services...
ChrysCapital invests $100m in India's Lenskart
ChrysCapital Partners has invested USD 100m in India’s Lenskart, bringing the eyewear retailer’s pre-IPO funding since the start of last year to USD 850m.
South by Southeast: Asia's next growth engine?
Grouping together markets based on growth and scale is a problematic with South Asia and Southeast Asia as it was with the BRIC economies. But to some extent, investors are buying into the story
Put a bow on it: India draws funds to GIFT City
India has created an onshore jurisdiction with offshore characteristics to lure country funds currently domiciled in Singapore and Mauritius. Does GIFT City have staying power?
Fund focus: ChrysCapital accumulates $1.4b India war chest
For ChrysCapital Partners, raising India’s largest private equity fund reflects the growth in the economy and in the investment opportunity, with bigger deals across more sectors on the agenda
India exits: Sustainable trend?
GPs saw abundant exits in India in 2021 and the flow continued last year even as other markets stumbled. Investors must assess the merits of various contributing cyclical and structural factors
ChrysCapital acquires US-India IT player Xoriant for $350m
India’s ChrysCapital Partners has acquired Xoriant, a US-headquartered but primarily India-based software engineering and IT provider, for about USD 350m.
Sequoia, ChrysCapital to exit India's Curatio
Sequoia Capital India and ChrysCapital Partners are set to exit Indian skincare brand Curatio, with Torrent Pharma agreeing to acquire 100% of the company for INR 20bn (USD 245m).
PE-backed Mankind Pharma files for India IPO
Indian drug maker Mankind Pharma has filed for a domestic IPO, setting up an exit for Capital International, a private equity arm of Capital Group.
India's ChrysCapital adds US-based operating partner
India's ChrysCapital Partners has appointed Sanjay Jalona, formerly CEO of the IT division of Indian engineering conglomerate Larsen & Toubro, as an operating partner based in the US.
ChrysCapital, GIC back $593m India asset management carve-out
ChrysCapital Partners and GIC have teamed up with Bandhan Financial Holdings – an Indian banking and financial services company – to acquire IDFC’s asset management business for INR 45bn (USD 593m).
GP profile: Creador
Creador claims to be Southeast Asia’s only middle-market GP with on-the-ground capacities across the region. But in-house post-deal support and nimble deal sourcing are its key differentiators
AVCJ Awards 2021: Exit of the Year – Mid Cap: Infogain
ChrysCapital has realized its largest-ever exit from a single-fund investment with IT services provider Infogain. In the process, it opened one of private equity’s richest cross-border opportunity sets
India logistics player Xpressbees raises $300m
The Blackstone Group, TPG Capital, and ChrysCapital Partners have participated in a USD 300m round for Xpressbees, an Indian logistics start-up established by the team behind mother-and-baby retailer FirstCry.
ChrysCapital, True North join $150m Quest Global deal
ChrysCapital and True North Managers have participated in a $150 million investment for a minority stake in Quest Global, an Indian engineering services outsourcing company.
PE & gambling: Ante up
Private equity has exhibited consistent appetite for gambling-related assets amid pandemic-fueled uncertainty. Regulation remains a significant wildcard in Asia. Reputational risk, not so much
ChrysCapital exits US-based Infogain to Apax
ChrysCapital has exited Silicon Valley-based Infogain – an IT services provider that helped solidify the US-India cross-border opportunity set – to Apax Partners.
Creador exits Indian pharma player to ChrysCapital
Creador has completed a third exit – with a 3.7x multiple and a 32% IRR – from its third South and Southeast Asia-focused fund, selling a minority position in Indian pharmaceutical company Corona Remedies to ChrysCapital.
India's Dream Sports raises $400m, hits $5b valuation
Dream Sports, operator of India’s largest fantasy sports platform, has raised $400 million in funding led by TCV, D1 Capital Partners and Falcon Edge Capital. The post-deal valuation is nearly $5 billion.
PE & Asian banks: Once-in-a-decade opportunity
GPs like targeting banks during downturns, investing in stronger players at discount valuations and backing them to come out the other side with increased market share. Will it be more of the same with COVID-19?
India fantasy sports platform raises $225m
TPG – acting through its tech adjacencies strategy – Tiger Global Management, ChrysCapital Partners, and Footpath Ventures have led a $225 million round for Dream Sports, operator of India’s largest fantasy sports platform.
Indian GPs tip more PE industry consolidation - AVCJ Forum
Indian private equity managers expect further industry consolidation as the survivors from the last wave refine their approaches to investment, including the slow crawl towards more control deals.